Antibody Therapy
The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's (LLY.N) COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness. The therapy,..
REUTERS Trial data from AstraZeneca (AZN.L) on Friday raised the prospect of a new treatment to prevent COVID-19 beyond vaccines, giving hope in particular for people who respond poorly to ...
.jpg)
.jpg)
.jpg)
.png)
.jpg)
